Study of Mannose Metabolites in Rat Tissues by Asikin, Nur
A STUDY OF MANNOSE METABOLITES 




Doctor of Medicine 
University of Indonesia 
Jakarta, Indonesia · 
1968 
Submitted to the Faculty of the Graduate College 
of the Oklahoma State University 
in partial fulfillment of the requirements 
for the Degree of 






A STUDY OF MANNOSE METABOLITES 
IN RAT TISSUES 
Thesis Approved: 




First and foremost I would like to say "Alhamdulillah", thanks to 
God for His guidance in the completion of this study. 
The author extends special appreciation to his major professor, 
Dr. R. E. Koeppe, for his guidance, advice and understanding. Apprecia-
tion is also expressed to Dr. R. K. Gholson, Dr. H. 0. Spivey and Dr. 
E. J. Eisenbraun for their help as advisory committee members. I am 
grateful to the entire staff and faculty of the Oklahoma State University 
Biochemistry Department who impart their knowledge and expertise and 
especially to Dr. F. R. Leach for his assistance in the culture of bac-
teria. 
Deep gratitude is expressed to Dr. S. S. Zahir andDr. A. Rasad fbr 
their support and guidance, and to Prof. M. Mardjono; they have made it 
possible for the accomplishment of this study. 
I am indebted to the China Medical Board of New York, Inc. and to 
the Oklahoma State University for the financial support that has made 
this work possible. 
Special gratitude is expressed to my parents who have their dreams 
materialized, and to my wife, Erma and our daughters, Rika and Dian, 
for their understanding and many sacrifices. 
iii 
TABLE OF CONTENTS 
Chapter 
I. INTRODUCTION 
II. MATERIALS AND METHODS 
Materials . . . . . 
Methods • . . . . . 
Preparation of Tissue Extracts 




Preparation of Tissue for Analysis 
Hexose-6-phosphates 
Mannose-1-phosphate 
Response to Sugar Loading 




Mannose-phosphates and Related Metabolites 
GDP-Mannose . . . . . 
v. SUMMARY 























LIST OF TABLES 
Table Page 
I. Concentration of Hexose-6-Phosphates in Liver, 
Kidney and Testes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 
II. Concentration of Hexose-6-Phosphates in 
Rat Brain • . . • . • . . . . . • • • 30 
III. Concentration of Hexose-6-Phosphates in Tissues 
of Suckling Rats . . . . . . . . . . . • . . . • . . . . . • . • . . . . • • . . • • • • . • • 32 
IV. Mannose-1-Phosphate Content of Rat Tissues 
v. Effect of Glucose Loading on Hexose-Phosphates 
in Rat Tissues . . . . . . . . . . . . . . 
VI. Effect of Fructose Loading on Hexose-Phosphates 
in Rat Tissues . . . . . . . . . . . . . . 
VII. Effect of Mannose Loading on Hexose-Phosphates 
in Rat Tissues 
VIII. ATP and Free Hexoses in Rat Tissues after Glucose 
and Fructose Loading 
IX. ATP and Free Hexoses in Rat Tissues after 
Mannose Loading 
X. Concentration of Metabolites as Reported in 
the Literature • . . . . . . . . • • . . 
v 
34 
. . . . 38 









Synthesis of "Core" Oligosaccharide 
Pathway of Mannose Metabolism in 


























LIST OF SYMBOLS AND ABBREVIATIONS 











- 6-phosphogluconic acid 
- uridine diphosphoglucose 
- guanosine diphosphofucose 
- guanosine diphosphomannose 










This study was carried out in an attempt to determine the concen-
tration of mannose metabolites in rat tissues. The interest of this 
laboratory in the study of mannose metabolism was first stimulated by 
the report, in 1972, of Sloviter et al. (1) that mannose could replace 
glucose as an energy substrate for perfused rat brain. After a fifty-
minute perfusion with either glucose or mannose, at a rate of 4 mg/min 
(0.022 mmol/min) the level of mannose-6-phosphate (Man6P) was found to 
be 320 and 475 nmol/g of tissue, respectively. The concentration of 
Man6P in the cerebral tissue of the normal rat was found to be similar 
to that of the isolated brain perfused with glucose. A year later (2) 
the isolation of Man6P from rat brain by ion-exchange chromatography 
was described. 
In the study above it was demonstrated that there was no substan-
tial change in the pattern of metabolism of the brain perfused with 
mannose compared to that perf~sed with glucose. Mannose maintains the 
energy reserves (adenine nucleotides, creatine phosphate) and oxidative 
status (lactate/pyruvate and a-glycerophosphate/dihydroxyacetone-phos-
phate ratio) of the perfused ti~sue, and ~oes not alter the levels of 
cerebral free amino acids, which appear to function as substrate reser-
voirs. 
An earlier study using the isolated,. perfused rat brain showed 
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that the electrical and metabolic activity of the brain was maintained 
just as well with mannose as metabolic substrate as with glucose (3). 
Samples of the perfusion fluid contained low levels of glucose (less 
than 20 mg/100 ml), indicating no appreciable conversion of mannose to 
glucose. 
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Mannose does not normally constitute an important part of an ani-
mal diet; however, the similarity in structure makes it conceivable 
that the body could utilize mannose in place of glucose. As early as 
1922 (4) mannose injection was shown to relieve the symptoms of hypo-
glycemia resulting from hepatectomy, and to restore to normal the 
electrical activity of brains of rabbits rendered hypoglycemic by hepa-
tectomy or by insulin injection (5). At that time it was thought that 
mannose was first converted to glucose by tissues other than the brain. 
Chain et al. (6) observed that rat cerebral cortical slices meta-
bolized (u-14c)mannose essentially like glucose based on oxygen utili-
zation, C0 2 production, and incorporation of radioactivity into lactate, 
aspartate, glutamate and y-aminobutyric acid. 
Studies on the metabolism of mannose have been done on tissues 
other than the brain. The utilization of mannose by adipose tissue and 
liver slices from normal and alloxan-diabetic rats was shown to be 
identical to that of glucose; the metabolism of both sugars was sup-
pressed in the diabetic tissues and stimulated by insulin (7). A simi-
lar finding was reported on the metabolism of both sugars by kidney 
slices of normal and diabetic rats, diabetic tissues showed a decreased 
incorporation of radioactivity into C02, fatty acids and glycogen (8). 
McNamara et al. (9) studied the transport and metabolism of 
(1- 14c)mannose in rat renal cortical slices. The uptake process appear-
.:' 
ed to be saturable and oxygen dependent and to be inhibited by glucose, 
galactose and phlorizin, indicating an interaction with the glucose 
transport system. 14C0 2 was produced at a rate comparable to that from 
glucose. Radioactive compounds accumulated in the tissue, about 50% of 
which were in the form of phosphorylated intermediates (precipitable by 
Ba(OH) 2 and ZnS0 4 ). The remaining neutral fraction, analyzed by gas-
liquid chromatography, cons~sted of mannose (83%), glucose (5%) and an 
unidentified compound which behaves like an alditol (9%). Assuming a 
direct conversion to glucose, the specific activity of glucose indicat-
ed that 28% of it was derived from mannose. An earlier study by Krebs 
and Lund (10) using slices of rat renal cortex incubated with 10 mM 
mannose showed that glucose was formed at a rate of 50 ~mol/h per gram 
of tissue. 
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It has also been observed, in slices of guinea pig skin, that 
respiration can be supported by mannose to the same extent as by glucose. 
Man6P was detected on paper radioautographs of normal skin maintained 
on glucose. Skin maintained on mannose produced chromatograms indis-
tinguishable from those of skin maintained on glucose (11). 
Mannose has a widespread occurrence in the plant and animal 
kingdom and it is a component of various cellular constituents of 
functional importance to organisms. The following is a list of some of 
the compounds shown to contain mannose: 
1) Cell-wall mannans of plants. The mannan of M.lysodeikticus was 
shown to be a lipopolysaccharide (12) and mannans in the yeast 
cell-wall provide structural functions as well as attachment sites 
for extracellular enzymes such as invertase and alkaline phos-
phatase (13). 
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2) Glycolipids containing mannose, inositol and phosphoryl-
ceramide have been described in yeast (14) and are related to the 
phytoglycolipids from various plant seeds (15). The glycolipid of 
the fungus U. maydis (16) contains erythritol, whereas those of 
mycobacteria contain diglyceride and have antigenic properties 
(17,18,19). 
3) A lipopolysaccharide of M. phlei containing 3-0-methyl mannose 
was shown to stimulate fatty acid synthetase by decreasing the Km 
for acetyl-CoA and malonyl-CoA (20). The 0-antigen of salmonellae 
consists of a repeating unit of the trisaccharide mannosylrhamno-
sylgalactose (21). 
4) Membrane glycoproteins serve an important role in cell-cell 
interaction, differentiation and growth, and as antigenic 
determinants (22). 
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5) Secretory glycoproteins, including egg-albumin (23), lactoferrin 
(24) and the plasma glycoproteins orosomucoid, transferrin, pro-
thrombin and fibrinogen (25). Also containing mannose are the 
immunoglobulins (26), luteinizing and follicle-stimulating hormones 
and thyroglobulin (25), the visual pigment rhodopsin (27) and the 
enzymes.· ceruloplasmin (superoxide dismutase) , hexokinase (22) and 
pancreatic ribonucleases and lipases (28,29,30). 
The carbohydrate moieties of several glycoproteins appear to have 
only a structural and not a functional significance. As an example, 
prothrombin, fibrinogen, transferrin and y-globulin have biological 
activities which appear to be independent of the bound carbohydrate. 
Ribonuclease A and B have identical amino acid sequences and differ only 
by a carbohydrate unit (in RNase B) but have identical substrate speci-
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ficity and enzymatic activity (25). 
A comparison between extracellular and intracellular proteins in-
dicated that the carbohydrate unit of extracellular proteins acts as a 
label which destines the proteins for secretion. It would seem logical 
that the carbohydrate unit, by interaction with an appropriate receptor 
or carrier, would act as a chemical passport for exit through the cell-
ular membrane (25). 
Glycoproteins could be classified into 3 types (31): 
1) Serum or plasma glycoproteins where each glycan unit is linked 
through an N-glycosidic bond between an N-acetylglucosamine (Glc-
NAc) residue at the reducing end of the unit and an asparagine 
(Asn) residue in the protein core. This type of glycoprotein con-
tains mannose at the core region. All plasma proteins, except al-
bumin, appear to be glycoproteins of this type. 
2) Mucin type glycoproteins usually have a di- or penta-saccharide 
unit linked to the threonine or serine residues of a protein chain 
through an a-S-glycosidic bond with N-acetylgalactosamine (GalNAc). 
These glycoproteins do not contain mannose or GlcNAc; most plasma 
membrane glycoproteins are of this type. (Yeast cell-wall mannans 
also have this type of linkage, with GlcNAc). 
3) Mucopolysaccharides or proteoglycans which are characterized 
by the presence of uronic acids and absence of sialic acids. 
In recent years active research in many laboratories has been con-
ducted to elucidate the mechanism and regulation of the biosynthesis of 
polysaccharides and glycoproteins in bacteria, yeast, plants and ani-
mals. The systems studied include bacteria (for review see 21), yeast 
(32, 33), mung bean (34), cotton-boll. (35), aorta (36), rat and calf 
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bral.n (37, 38), rat and bovine thyroid (39 ,40), pig liver (41), bovine 
retina (42), chicken oviduct (43) and human lymphocytes (44). 
What might now be considered the classical pathway for the biosyn-
thesis of complex carbohydrates involves the sequential transfer of in-
dividual monosaccharides from their nucleotide derivatives to acceptor 
molecules in a process mediated by specific glycosyl-transferases. 
Knowledge of the overall biosynthetic pathway is still incomplete; not 
all the steps have been rigorously documented and none of the enzymes 
involved have been isolated and purified. 
It is evident that lipid bound sugars are intermediates in the 
biosynthetic process. The lipid moieties of the glycolipid intermedi-
ates in bacterial and plant systems have been shown to be polyisopren-
oids of 10- 12 isoprene units (bactoprenol, betulaprenol), whereas the 
dolichols, a class of polyisoprenoids containing 17 - 22 isoprene units 
with a saturated terminal (alcohol end), are lipid carriers found in 
mammalian systems and yeast. 
The mannose containing glycoproteins of animals appear to have a 
common "core" region in their oligosaccharide chain, having the general 
structure: 
(Man) -Man(1-4)-GlcNAc(1-4)-GlcNAc- Asn(polypeptide) 
X 
This core unit may or may not have an attached side chain of GlcNAc, 
galactose and sialic acid (or fucose). 
Cytological and radioautographic evidence indicate that the glyco-
protein being synthetized flows from the rough and smooth endoplasmic 
reticulum through the Golgi apparatus and secretory vesicles to the 
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plasma membrane and extracellular space or to intracellular structures 
such as lysosomes. The core unit is first synthetized attached to the 
lipid carrier as shown in Figure 1, and then transferred in toto to the 
growing peptide chain in the rough endoplasmic reticulum (43). The 
addition of terminal sugars occurs in the smooth endoplasmic reticulum 
' 
and the Golgi apparatus (39,45), where the nucleotide sugar derivatives 
(UDP-GlcNAc, UDP-Gal, UDP-Glc and GDP-Fuc) appear to be the donor mole-
cules. Inversion of anomeric configuration usually occurs at each gly-
cosylation such that the configuration of the newly attached sugar is 
opposite to that in the donor. 
The presence of the tripeptide sequence Asn-X-Ser(Thr) appears to 
be necessary but not sufficient for the protein to serve as acceptor, 
suggesting that the unfolding of the polypeptide chain is required to 
expose the appropriate Asn site and that the polypeptide folding may 
play an important role in the regulation of protein glycosylation (46). 
The glycosyltransferases in the membranes of the smooth endoplasmic 
reticulum and Golgi apparatus exhibit a high degree of specificity for 
sugar donor and for the oligosaccharide structure of the glycoprotein 
acceptor (47), thus adding another control mechanism. 
Of interest is the possible involvement of vitamin A (retinol) as 
a lipid carrier in glycoprotein biosynthesis. It was well known that 
epithelial cells generally lose their mucus secreting ability in vitamin 
A deficiency and may be keratinized (cornea) or not (intestine). The 
goblet cells of vitamin A deficient rats showed an impaired synthesis of 
fucose containing glycoproteins (48). · Retinyl-phosphate was shown to 
function as an acceptor of mannose from GDP-Man in an in vitro system 
from rat liver membranes; the incorporation of labelled mannose into 
UDP ~ GlcNAc 
1 
Dol-P-P ~ GlcNAc 
t-- UDP .<!. GlcNAc 
Dol-P-P ~ GlcNAc ~ GlcNAc 
a. GDP - Man 
1 
I 
a. s s 1 
nDol-P ~ Man 
I 
Dol-P-P - GlcNAc - GlcNAc - Man 
1 
a. s s a. Dol-P-P- GlcNAc- GlcNAc -Man- (Man) 
n 
Polypeptide --------------------,1 
Polypeptide ~ GlcNAc ~ GlcNAc ~ Man ~ (Man) 
n 
Figure 1. Synthesis of "core" Oligosaccharide. 
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glycolipid and glycoprotein decreased by 60 - 90% in mild and severe 
vitamin A deficiency compared to that of vitamin A fed hamsters (49). 
It was also observed that mannosyl-retinyl phosphate represents 5 - 10% 
of the total labelled mannolipid synthetized by normal rat liver mem-
branes from labelled GDP-Man, the remainder being dolichol-P-Man (SO). 
Brunngraber et al. (51) described mannose-rich glycoproteins from 
rat brain, over SO% of which are localized in the synaptosomal and 
microsomal fractions. Margolis et al. (52) isolated mannose-ric~ glyco-
peptides from Pronase digested rat brain nuclei and also studied the 
developmental changes in rat brain glycoprotein. Between 1 - 30 days 
postnatal a larger increase (2 - 3 times) was observed in the core sugars 
than in those of the side chain, suggesting a preferential synthesis of 
glycoproteins containing primarily "core" units (37). 
We owe much of our understanding of polysaccharide and glycoprotein 
biosynthesis to L.F.Leloir, who first discovered the sugar nucleotides 
which were later shown to function as glycosyl donors. UDP-glucose was 
discovered (53) in yeast in 1949 and GDP-mannose in 1953 (54). GDP-Man 
was later detected in several animal sources: bovine aorta, 8 nmol/g 
(55), hen egg-white, 0.18 ~mol/ml, representing 90% of the total nucleo-
tide (56), hen oviduct (isthmus), 11 nmol/g, and uterus, 0.1 nmol/g 
(57), rabbit uterus, 70 nmol/g (58) and human red-blood-cells, 20- 60 
nmol/ml (59). More GDP-Man was found in colostrum than in milk; the 
colostrum of cow, human and pig, respectively, contains 1.9, 0.11 and 
34 ~mol/100 ml (60,61). 
GDP-Man formation is catalyzed by the enzyme GDP-Man pyro~hospho­
rylase. The enzyme was first described in yeast (62) and later in bac-
teria and algae (63,64). Hansen el al. (65,66) found that calf liver 
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and bovine and rat mammary gland were good sources of the enzyme; no 
activity was detected in hen oviduct. The enzyme is nonspecific for the 
nucleotide or sugar moiety; in decreasing order of activity, GDP-, IDP-, 
and ADP-hexoses are substrates with either glucose or mannose as the 
sugar moiety. The reaction catalyzed by the enzyme is reversible, thus: 
GTP + Man lP t==~ GDP-Man + PPi 
Fucose in glycoproteins is incorporated from GDP-fucose, which is 
formed from GDP-Man by the enzyme GDP-mannose oxidoreductase. The reaction 
was first described in A.aerogenes and requires NADPH (67). GDP-fucose 
was found in cow (30 nmol/ml) but not in human colostrum (60). 1-fucose 
was found in human milk (6.7 ~mol/ml) and (6-14C)fucose was recovered in 
human milk after intravenous administration of (6-14c) glucose (68). Of 
interest also was the oxidation of GDP-Man to GDP-mannuronic acid in the 
soil bacteria A. viscosus (69). This reaction is catalyzed by GDP-Man 
dehydrogenase and requires NAD. 
From the discussion above we see that glucose can be converted to 
Man6P and the mannose moiety of glycoproteins. Using calf thyroid slices 
incubated with labelled glucose, Spiro and Spiro (70) demonstrated an 
early incorporation of radioactivity into the galactose moiety of thyro-
globulin. Mannose was labelled after one hour and sialic acid after 
two hours. 
On the other hand, available mannose is incorporated into glyco-
proteins and enters the glycolytic pathway to serve as a source of 
energy. How is this interconversion carried out? Sols and Crane (71) 
reported that manr10se is phosphorylated by hexokinase to Man6P, and 
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Chulkoff et al. (72) reported mannokinase activity in rat tissues. 
The enzyme phosphomannose isomerase (PMI), which is distinct from 
phosphoglucose isomerase (PGI) and interconverts fructose-6-phosphate 
(Fru6P) and Man6P, was first described in rabbit muscle (73). Noltmann 
et al. (74) demonstrated the presence of PMI in the tissues of pig and 
rat, and separated the yeast PMI from PGI (75). The yeast enzyme was 
further characterized by Gracy and Noltmann (76) and was shown to be a 
zinc metalloenzyme of molecular weight 45 000. 
A question concerning the pathway from glucose to GDP-mannose is 
how is Man1P formed? Thus far Man1P has only been reported to be present 
in the mold P. chrysogenum, about 90 mg being recovered, by calcium 
acetate and ethanol fractionation, from 1 kg of mycelium (77). In 1959, 
Glaser (78) reported the presence of a distinct phosphomannomutase (PMM) 
in yeast, catalyzing the interconversion of Man6P and Man1P. The ~'s 
for glucose-1,6-bisphosphate (Glc(1,6)P2) and mannose-1,6-bisphosphate 
(Man(1,6)P2) are 0.16 and 0.12 mM, respectively, which are higher than 
the corresponding Km's of muscle or yeast phosphoglucomutase (PGM). The 
enzyme has not been reported in animal tissues even though it was 
assumed to function in the synthesis of fucosyllactose in milk (79). 
It is possible that the interconversion of Man6P and Man1P is 
catalyzed by PGM, however the reaction is much slower than that for 
Glc6P and Glc1P. The yeast enzyme has a Km and Vm for Man1P of 245 ~M 
and 19.4 ~mol/mg per min, respectively. The corresponding values for 
Man6P are 500 and 0.2, and for Glc1P, 8 and 328. 
Another branch of the metabolism of mannose is the formation of 
L-neoinositol-1-phosphate (nlns1P) from Man6P. This reaction is cata-
lyzed by hexose-6-phosphate inositol-1-phosphate cyclase, the same 
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enzyme for the formation of L-myoinositol-1-phosphate from Glc6P (81). 
Neo-inositol has been identified from calf brain by gas-liquid chromato-
graphy mass spectrometry of its trimethylsilyl- and acetate esters. The 
compound is present in micromolar amounts in rat tissues except liver, 
the highest concentration (14 ~M) being in the testes (81). 
The metabolism of mannose is depicted in Figure 2. Man(1,6)P 2 
which is supposed to be the intermediate/coenzyme in the mutase reaction 
(PGM,PMM) was found in the erythrocytes of humans and various mammals at 
a concentration of 0.1- 0.2 ~mol (phosphate) per ml (82). This metabo-
lite was shown to be an effective activator of red cell pyruvate kinase 
in vitro (83), and considering its high concentration it may well function 
as an important metabolic regulator. 
Rose (84) has recently reported that mouse brain contains an enzyme, 
glucose-1,6-bisphosphate synthase, catalyzing the reaction: 
glycerate-1,3-P 2 + Glc1P 
glycerate-3-P + Glc(1,6)P 2 
Glc6P and Man1P were good alternate acceptors suggesting that this 
enzyme might function in the synthesis of Man(1,6)P2. However, the 
enzyme was later shown to be inhibited by physiological concentrations 
of fructose-1,6-bisphosphate (Fru(1,6)P 2), Glc(1,6)P 2, phosphate and 
citrate ( 85) . 
In this study I determined the concentration of the metabolites of 
mannose, Man6P and Man1P, in brain and other tissues of rat. The effects 
of animal age and of the injection of sugar precursors, glucose, fructose 



















Glycolipids, glycoproteins and peptidoglycans 
Figure 2. Pathway of Mannose Metabolism 
in Plants and Animals. 
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the highest concentration of Man6P and Man1P was found in the liver, 
about 100 and 15 nmol/g, respectively. Mannose loading resulted in a 
variable but significant increase of liver Man6P and Man1P, with an 
apparent decrease in ATP. 
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CHAPTER II 
MATERIALS AND METHODS 
Materials 
Glucose, fructose and perchloric acid were from J. T. Baker. ATP, 
NADP, GDP-Man, hexose-phosphates, mannose and triethanolamine (TEA) 
1,base were from Sigma. PMI was from Boehringer, the other enzymes were 
from either Boehringer or Sigma. Hydroxyapatite (Biogel-HTP) and the 
ion-exchangers AG1-X4, 100-200 mesh and AG50-X4, 50-100 mesh were from 
Bio-Rad. Charcoal (Norit A) was from Matheson. Polyethyleneimine (PEl) 
cellulose thin layer plates were from Analtech. 
Deionized distilled water was used for the preparation of reagents 
and solutions. All solutions, samples and enzymes used in fluorometric 
assays were filtered through 0.45 ~ Millipore filter. 
Absorbance measurements were carried out on a Hitachi-Perkin-Elmer 
model 124 spectrophotometer equipped with a Coleman 165 recorder. A 
Johnson Research Foundation Metabolite Fluorometer was used for fluo-
rescence measurements. The fluorometer is supplied with a low pressure 
mercury lamp and an excitation filter with maximum transmission at 
355 nm and 53 nm half-width, thereby allowing the 334 and 365 nm mercury 
lines to pass through. Filters were used on the emission side to exclude 
wavelengths below 420 nm and above 500 nm (86). 
Chromatographic eluates were monitored at 254 nm using an ISCO 




Preparation of Tissue Extracts 
In the earlier part of this study, tissues were obtained from rats 
frozen whole in liquid nitrogen. As this method did not permit quick 
freezing of the tissues of interest and gave results that did not ref; 
lect in vivo conditions, the method was later abandoned except for 
smaller animals (about 60 g or less). 
Female Boltzmann rats were used throughout, except for the young 
ones and, of course, for testes. They were brought to the laboratory 
and acclimated to handling for at least two days before being killed; 
they were allowed free access to food and water. 
The rats were usually killed around 10 - 12 A.M. Each was anesthe-
tized first by placing in a jar containing Kimwipes saturated with 
ether, the lid ( a used TLC plate ) being opened just enough so the 
animal could not escape. As soon as the rat became unconscious, it was 
placed on the lab bench, with the head in a beaker containing Kimwipe 
saturated with ether. 
The skin above the forehead was removed and the abdominal cavity 
was exposed by making a midline incision towards the diaphgragm and 
laterally along the costal margin. The rat was then immersed in the 
refrigerant (liquid nitrogen) and the desired tissues were chiseled out 
from the frozen carcass. When the brain was not required the tissues 
desired were excised and press~d with a porcelain pestle (precooled 
with liquid nitrogen) in a mortar filled with refrigerant, a flattened 
tissue was obtained within 5 sec after excision. Blood was obtained 
from a cut of the tail and collected in a tube, cooled in an ice bath, 
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containing the appropriate amount of potassium oxalate as antocoagulant. 
A sample of whole blood was quickly deproteinized for assay. 
Glucose, fructose or mannose was injected intraperitoneally, under 
ether anesthesia, at a dose of 20 mmol/kg body weight given as a 25% 
solution. The animal was allowed to recover and after an appropriate 
interval was reanesthetized and killed; a successful injection was indi,-
cated by the accumulation of fluid in the abdominal cavity. 
Fat and excess blood were removed from the tissues obtained by 
either of the procedures above without allowing them to thaw (periodic 
immersion into liquid nitrogen). They were put in a steel mortar sur-
rounded by dry ice and pulverized. The tissue powder was transferred 
with a scoopula (precooled with liquid nitrogen) into a glass homogeniz-
ing tube cooled in dry ice. The weight of the powder was determined by 
the difference of the weight of the tube before and after the addition 
of the powder; weighing was done on a Torbal torsion balance or, more 
conveniently, with a Fisher electronic balance (thanks to Ms. Judy Hall 
for lending the balance). 
When the recovery of a metabolite was determined, the tissue pow-
der was transferred into two homogenizing vessels and, after weighing, 
a known amount of the solution of the metabolite (i.e. hexose-phosphate) 
was added to one of them. On a given day this was done only with one of 
the tissue samples; the recovery of the other samples was assumed to be 
identical. 
The tissue powder was deproteinized by adding 4 to 6 volumes of a 
mixture of 8% perchloric acid-40% ethanol (PCA-EtOH) (87) and, after 
mixing well and standing in an ice bath, homogenized in the Potter-
Elvehjem homogenizer with a Teflon pestle. The homogenate was trans-
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ferred with a Pasteur pipet into a round-bottomed centrifuge tube. The 
residual homogenate was quantitatively transferred by the addition of 
1 ml, 0.5 m1 and 0.5 m1 of PCA-EtOH, homogenizing each time before 
transferring to the centrifuge tube. This method gave a satisfactory 
recovery arid there was no need to rehomogenize the protein pellet after 
centrifugation, as was later found to be verified in the literature 
(88). 
The homogenate was centrifuged at 10 000 x g for 20 min in the 
SS-1 rotor of a Servall centrifuge. The supernate was transferred into 
another centrifuge tube and neutralized to a pH of about 6 by the slow 
addition of 3 M K2 C0 3 containing 0.5 M TEA base (87) while mixing with 
a magnetic stirrer. In later experiments where Man1P was to be deter-
mined, neutralization was done with 5 M KOH; the use of a buffer was 
a disadvantage here because of the requirement of alkaline and acid 
conditions for hydrolysis. 
Since the extracts of liver and kidney were yellowish brown in 
color and highly fluorescent, charcoal was added at 10-20 mg/ml for 
decolorization (89). It was observed that charcoal should be added 
before neutralization was carried out, otherwise decolorization was 
not efficient. For nucleotide determination, an aliquot of the homo-
genate was used without decolorization. The charcoal used in this study 
was prewashed (100 g) successively with 2 1 of 1 M HCl, 2 1 of 1 M 
ammonia and water until neutral followed by drying for 18 h in an oven 
at 110°c (90); the charcoal was then stored in a tightly stoppered 
bottle. 
Potassium perchlorate was allowed to precipitate for 30 min in the 
cold followed by centrifugation at 10 000 x ~ for 30 min. The neutral-
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ized extract, stored at.4°C for 5 days, showed no change in hexose-6-
phosphate concentration. ATP was usually determined on the same day, 
although Williamson mentioned that hexose mono- and di-phosphates and 
ATP were stable for at least 4 days (88). Aliquots for the determina-
tion of ManlP, which is stable in alkali, were immediately treated with 
KOH to 0.05 N and stored at 40c before further treatment. Assays were, 
always completed within one week after the preparation of homogenates. 
Assay of Metabolites 
General. All assays were carried out in 0.1 N TEA buffer pH 7.6 at 
30°C. ATP and glucose, or fructose and mannose after injection of the 
sugars, were determined spectrophotometrically; the hexose-phosphates 
were determined on the fluorometer. In each case the metabolites were 
determined by an enzymic assay using a reaction coupled to glucose-6-
phosphate dehydrogenase (G6PDH) and measuring the increase in absorbance 
or fluorescence of the NADPH being formed (87,91). 
The reactions were as follows: 
GlclP 
r~ 
Man6P PMI Fru6P PGI Glc6P G6PDH ~ 6PGlcA - - (\ I HK, t I -H-Mg ' ATP NADP NADPH 
Man Fru Glc 
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Assays were done in 2 ml final volume containing the indicated 
quantities of the following reagents as appropriate: MgCl2, 3 mM; ATP, 
500 ]..!M; NADP, 400 J..!M; PMI (yeast), 1.5 U; HK (yeast), 1.5 U; PGI 
(yeast), 1 U; PGM (rabbit muscle), 1 U; G6PDH (yeast), 1 U; glucose, 
1 mM. 
Under the conditions described above the PMI reaction was completed 
in 15 to 20 min. After the Man6P portion of the assay was started by the 
addition of PMI, the cuvette was set aside in the incubation chamber of 
the fluorometer and a second assay was started. After the addition of 
PMI to the second cuvette, the first sample was returned to the assay 
chamber, care being taken to put it in the original alignment, and the 
fluorescence increase was read. In this way the total assay time was 
reduced substantially. 
The size of the sample was chosen so that the total increase in 
absorbance was 0.4 or less to ensure a linearity in the response. For 
the same reason the total amount of metabolites being sequentially 
assayed was made less than 20 nmol/2 ml (fluorometric). 
The amount of metabolite was calculated assuming a molar absorbance 
of NADPH of 6.22 x 106 cm- 1Mrl. The fluorometer was standardized by 
determining the fluorescence developed using a solution of glucose, 
Glc6P or NADPH of known ab,sorbance or concentration. 
Determination of Hexose-6-phosphates. Glc6P, Fru6P and Man6P were 
measured sequentially by the addition of G6PDH, PGI and PMI to the assay 
mixture. Some batches of PMI contain PGM activity, therefore PGM was 
added before PMI to remove any Glc1P present which might otherwise give 
an overestimate of Man6P. In this case EDTA, an activator of PGM, was 
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added at a final concentration of 0.1 mM. 
Determination of Free Hexoses. Glucose was measured by the addition 
of HK after the measurement of Glc6P. The addition of PGI gave fructose 
and the addition of PMI, mannose and Man6P. The free fructose and mannose 
were then obtained by subtracting the Fru6P ~nd Man6P readings in the 
absence of HK from those in its presence, respectively. 
ATP Determination. ATP was measured, after Glc6P was assayed, by 
the addition of HK and glucose. The use of yeast HK makes the method 
specific for ATP compared to other nucleoside triphosphates; the speci-
ficity was poorer with hexokinase from animal sources (92). 
Determination of Man1P. Advantage was taken of the differences in 
stability towards acid and alkali of hexose-1-phosphates and the reducing 
sugars (free hexoses and their 6-phosphates) (93). Hexose-1-phosphates 
are stable in alkali while acid hydrolysis releases an equivalent amount 
of phosphate and the respective free sugar. Reducing sugars on the other 
hand are relatively stable in dilute acid whereas treatment with alkali 
results in a complex reaction with the formation of various degradation 
products, among others, phosphate, saccharinic acids and lactate. 
In the determination of Man1P, the reducing sugars were first 
destroyed by boiling in a water bath for 30 min in 0.05 N KOH. Acid was 
then added, HCl or H2 S0 4 ,to a concentration of 0.1 N, the pH checked 
with pH paper, and hydrolysis was conducted for 20 min in a boiling 
water bath. A large amount of glucose was found after the acid hydrolysis 
(none was detected after the treatm~nt with alkali), originating from 
Glc1P and UDP-Glc. 
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Neither free hexoses nor hexose-6-phosphates were detected in the 
sample after the treatment with alkali. After the. subsequent acid hydro-
lysis, Glc6P and Man6P were detected. Presumably they represent the 
respective 1,6-bisphosphates that were originally present in the sample. 
Free glucose and mannose that were detected after the subsequent acid 
hydrolysis originated from the respective !-phosphates. 










After acid hydrolysis, assays were carried out with and without 
hexokinase. ManlP was determined from the difference of the total (man-
nose + Man6P) found in the presence of HK and of Man6P alone when HK 
as omitted. 
Assay of GDP-mannose. Two methods were tried in an attempt to 
measure GDP-Man in rat tissues. The experiments were done on extracts of 
rat liver which, because of its size, might contain a readily detectable 
level of the nucleotide. 
In the first method the following strategy utilizing a combination 
of chromatographic techniques was tried. Nucleoside monophosphates and 
the sugar nucleotides were separated from the nucleoside di- and tri-
phosphates by chromatography on hydroxyapatite (HA), the polyphosphates 
were retained on the HA column whereas the monophosphates and sugar 
nucleotides were eluted with 1 mM potassium phosphate buffer pH 6.8 (94). 
The sugar nucleotides were then separated from the monophosphates on an 
anion exchange column, AG1-X4 (Cl-), with a CaC1 2 gradient (95). The 
nucleotides were further characterized by ion exchange TLC on PEl-
cellulose (96). 
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In a typical experiment a neutralized PCA extract from 6 g liver, 
diluted to about 60 ml, was applied onto an 8 ml column of HA in a 10 ml 
disposable syringe. After the sample passed through, the column was 
washed with the phosphate buffer at a rate of about 1 ml/min. About 
25 m1 buffer was used; however, the amount and flow rate were not criti-
cal as the purpose was to collect the whole eluate and buffer wash until 
the absorbance became negligible. The combined wash and eluate was 
applied directly onto a 10 x 0.8 em column of AG1-X4 (Cl-) and allowed 
to pass through at a rate of 0.5 ml/min. The column was then washed with 
5 mM HCl until the absorbance became negligible ( < 0.02 ), when a 
CaCl 2 gradient was started. The mixing chamber contained 200 ml of 5 mM 
HCl and the reservoir 200 ml of _0.2 N.CaCl 2 in 10 mM HCl; fractions of 
about 4 ml were collected. GDP-Man was expected to elute towards the 
end of the gradient. The whole operation was carried out in a cold room. 
The fractions that were thought to contain GDP-Man were combined 
and neutralized with a suspension of Ca(OH) 2, concentrated by vacuum on 
a rotary evaporator (below 40°C) and lyophilized. To the dried material 
was added cold ethanol/ether (1:1, v/v), and the sample was kept in a 
freezer overnight. CaCl2 ~emained in solution whereas the calcium salt 
of the nucleotide was precipitated and centrifuged out. This calcium 
salt was dissociated by the addition of ammonium oxalate and the calcium 
oxalate was centrifuged out. 
The nucleotide was applied to a PEl-cellulose layer, along with 
nucleotide standards, and developed (ascending) with either 1 M LiCl2 
or 2M Na-formate pH 3.4 (96). The nucleotide spots were detected by 
examining under short-wave UV light. 
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In the second method it was hoped to measure GDP-Man directly by 
following its oxidation to GDP-mannuronic ~cid; the reaction, catalyzed 
by GDP-Man dehydrogenase, consumes 2 mol NAD per mol GDP-Man oxidized. 
An attempt was made to isolate the enzyme from A. viscosus accord-
ing to Preiss (69,97). The bacteria (kindly supplied by Dr. L. K. Naka-
mura of the U.S.D.A., Northern Regional Research Center) was grown in 
several 1 1 batches in a medium of 3% glucose, 0.3% casein hydrolysate, 
0.4% K2HP0 4 , 0.08% MgS0 4 .7H20, and 0.005% MnS0 4 (adjusted to pH 7.0 with 
H2S0 4 ). After 16 to 24 h incubation at 28oc, the cells were harvested by 
centrifuging the culture at 3°C for 1 h at 10 000 x g. The bacterial 
precipitate was washed with cold 0.9% NaCl until free of polysaccharide. 
The cells were then stored in the freezer ( -12°C) until used. 
The frozen cells were suspended in 3 volumes of 50 mM Tris buffer 
pH 7.5, containing 5 mM glutathione (GSH) and 10 mM MgCl2• The cells 
were disintegrated by sonication for 30 sec using a Raytheon sonicator; 
the treatment being repeated 10 times. 
All operations were carried out in the cold. The cell debris was 
centrifuged off at 30 000 x g for 10 min and the supernatant recentri-
fuged for 1 h at 105 000 x g. To the supernatant (105 000 x g) from 
15 g cells was added 34 m1 of 1% protamine sulfate, with continuous 
stirring, and after 10 min the suspension was centrifuged for 10 min at 
26 000 x g. The supernatant was discarded and the precipitate extracted 
twice with 43 m1 0.3 M K-phosphate buffer (pH 7.0, 10 mM GSH). To the 
combined extracts (80 ml) was added 34 g solid ammonium sulfate; the 
dehydrogenase precipitates. The suspension was centrifuged for ·10 min 
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at 26 000 x g and the precipitate dissolved in 20 mM K-phosphate buffer 
(pH 7.0, 10 mM GSH). The solution was then dialyzed overnight against 
500 ml of phosphate buffer/GSH. 
Calculations 
The concentrations of hexose-6-phosphates and mannose-1-phosphate: 
were corrected for the amount of a known addition of the respective 
metabolites being recovered from each tissue sample; the calculations 
were as shown in the Appendix. Recovery determinations were not attempted 
on ATP and the free hexoses. No attempts were made to correct for the 




The fluorometer is a sensitive instrument; a great deal of effort 
was taken to eliminate or minimize noise. The most troublesome causes 
are specks of dust or paper fibers; filtration of all solutions, includ-
ing enzymes, through a 0.45 micron Millipore filter solves the problem. 
To avoid introduction of dust into filtered solutions, a Cornwall syringe 
and Eppendorf pipets were used for transfer; ordinary pipets were never 
used. Kirnwipes should never be used; lens paper was used instead. 
The earlier part of this study was frustrating because of slow and 
erratic response of the fluorometer; the data obtained had to be disc~rd­
ed. Only much later was it suggested1 that the problem might be due to 
magnetic influence on the photomultiplier tube; the problem was then 
solved by demagnetization of the tube using an AC magnetizer/demagnetizer 
(Brookstone Co, Worthington, MA) 2 • 
Preparation of Tissue for Analyses 
Originally tissues were obtained from live animals frozen in situ 
1Joanna Ledford, personal communication. 
2Supplied by Mr. Troy Barnes. 
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in liquid nitrogen. However; the results obtained were variable, with 
evidence of anoxic changes, namely, increase of Glc6P in the liver and 
a decrease in brain. The procedures mentioned under "Materials and 
Methods" (methods II and III of Table I and method III of Table II) were 
therefore adopted which, with consistency in their execution, probably 
gives a valid measure of the concentration of metabolites in vivo. 
The results obtained for liver, kidney and testes are shown in 
Table I. There is essentially no difference between the values obtained 
after immersion into liquid nitrogen of the individual tissue (liver) or 
of the whole animal with the abdominal cavity exposed. Anoxic changes 
are obvious in the tissues obtained by immersion of the live animals. 
Freeze-clamping of liver and kidney was tried on several occasions; 
the concentrations, in the liver of a 100 g rat, of Glc6P, Fru6P and 
Man6P were 463, 141 and 122 nmol/g, respectively. The tool used was a 
vise-grip sheet metal clamp obtained from a local hardware store and 
modified in the University's physical shop to increase its cooling capa-
city by attachment of aluminum blocks. 
The values above, indicating anoxic changes, were from liver clamped 
after securing blood from the tail vein. Better results might be obtained 
with practice and without such manipulation. However, the method was 
abandoned because of the tedious procedure for obtaining the tissues, 
especially the kidney, from which the adhered perirenal fat has to be 
removed from the frozen tissue. 
Brain, which presents a special problem because of its anatomy, 
could not be frozen within a reasonable time by immersion, except with 
smaller animals. The best approach to date is freeze-blowing (98) whereby 
air under pressure enters the cranial cavity through a steel probe and 
the supratentorial portion of the brain is forced out through another 
probe into a chamber precooled in liquid nitrogen. Siesjo et al. (99) 
described the freezing of brain in situ after exposing the skull by 
surgery under anesthesia; the animal was kept ventilated during the 
freezing process which takes several minutes to complete. 
The concentration of Glc6P, Fru6P and Man6P in brains from 75 to 
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150 g rats are shown in Table II. The concentrations of these metabolites 
are lowest in brains from animals frozen by immersion in liquid nitrogen 
or decapitated and the severed head dropped directly into the refrige-
rant. The level of Glc6P obtained by the procedure adopted in this study 
(method III of Table II) is comparable to that obtained by freezing of 
the brain in situ after surgical exposure (99). The highest values are 
from brains obtained by freeze-blowing 3 • 
The possibility of storing tissues in the deep-freeze ( -70°C ) 
with later process~ng at a convenient time was investigated. Contrary 
to the statement that tissues could be thus stored safely for several 
weeks (100), it was found that liver Glc6P arid Fru6P decreased, after 
one week, by about 20%, while Man6P was essentially unaltered. 
Hexose-6-phosphates 
The concentration of hexose-phosphates was calculated without cor-
rection for contamination by blood; recoveries (for calculation see 
Appendix) varied between 73 and 97%. The results for the hexose-phos-
phates as obtained by the procedures mentioned above are within the 
normal values obtained by freeze-clamping or by immersion as compiled 
3Thanks to Drs. R. L. Veech and T. King for the brain sample. 
TABLE I 
CONCENTRATIONS OF HEXOSE-6-PHOSPHATES 
IN LIVER, KIDNEY AND TESTES 
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Tissue * Method ** Glc6P Fru6P Man6P 
Liver I (3) 
II (3) 
III (9) 
490 ± 68 
278 ± 27 
294 ± 10 
81 ± 9 
70 ± 20 
72 ± 5 
130 ± 13~ 
97 ± 22 
99 ± 6 
Kidney I (2) 25 10 13 
III (6) 42 ± 4 12 ± 2 29 ± 4 




Number of observations in brackets. 
Method I Immersion of live animal into liquid nitrogen. 
Method II Rats anesthetized with ether, the abdominal cavity 
exposed and the whole animal immmersed in refrigerant. 
Method III: As in method II, the tissue excised and plunged in 
the refrigerant. 
Results are in nmol/g ( ± S.E.), corrected for recoveries, from 
200 - 250 g female rats. 








CONCENTRATION OF HEXOSE-6-PHOSPHATES 
IN RAT BRAIN 
Glc6Pt Fru6P 
48 ± '3.5 10 ± 1.2 
39 ± 0.3 12 ± 0.6 
92 ± 1 19 ± 1 
134 ± 12 31 ± 5 
Number of observations in brackets. 
Method I Immersion of live animal into liquid nitrogen. 
Man6P 
23 ± 3 
21 ± 2 
21 ± 4 
51 ± 3 
Method II Rats anesthetized with ether and the head decapitated 
into liquid nitrogen. 
Method III Same as I, except the skin of the forehead was removed 
under ether anesthesia. 
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Method IV Freeze-blown samples obtained from Drs. Veech and King, 
kept in deep-freeze (-7o0c) several weeks. 
t . 
Results from 75 to 150 g rats. Values are in nmol/g ( ± S.E.), 
corrected for recoveries. 
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by Williamson and Brosnan (101) 
Suckling rats were used to provide tissue samples that could be 
quickly frozen without undue manipulation or stress; the results are 
shown in Table III. A comparison of these levels of metabolites with 
those obtained from older rats reveals some significant differences. 
The concentration of Glc6P in suckling rats is higher in the kidney and 
brain and lower in liver. The values obtained from the suckling rats 
are comparable to those obtained from freeze-blown brains of older ani-
mals. The young and older rats have similar Fru6P levels in brain and 
kidney. However, liver Fru6P is higher in the older age group. 
As far as we are aware this is the first study of Man6P and Man1P 
in animal tissues other than the brain. The concentrations of Man6P in 
brain obtained by freeze-blowing and that of sucklings are similar; these 
values are higher than those obtained by other methods but significantly 
lower than that reported by Sloviter et al. (1). Older rats have higher 
concentrations of Man6P in liver. The two age groups have similar values 
for kidney. 
The report that testes contains nee-inositol, which is derived from 
Man6P (81), prompted a study of that organ. The results, obtained from 
350 g rats, are presented in Table I. 
Mannose-1-phosphate 
There has been no report on the determination of Man1P in animal 
tissues. Since the concentration is expected to be low, the lack of a 
specific enzymatic assay system presents a technical problem. Free and 
other phosphorylated sugars which are present in much higher concentra-






CONCENTRATION OF HEXOSE-6-PHOSPHATES 













Rats 2 weeks old ( 20 g) were used, frozen by immersion,'The 
values are from individual experiments, in nmol/g; those for brain 
and kidney are from 2 or 3 rats combined. 
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as mannose or phosphate. 
Several methods have been tried, giving similar results ( see 
Table IV) with recoveries varying between 60 and 110%. The first method 
removes mannose, fructose, glucose and their 6-phosphates by enzymatic 
conversion to 6-phosphoglucona:te (see diagram under "Methods"). Incuba-
tions were carried out at 300c and aliquots were tested at intervals for 
the completeness of the reaction. The reaction was quenched with either 
PCA or H2S04. Man1P was then determined after hydrolysis with alkaline-
phosphatase according to Grassl (102) and the liberated mannose assayed 
as mentioned previously. Hydrolysis can be done chemically using 0.1 N 
H2S04 and boiling in a water bath for 20 min. Free mannose is assayed 
enzymically after neutralization and precipitation of sulfate as BaS0 4. 
The second method is based on the principle that reducing sugars, 
namely hexoses and their 6-phosphates, can be converted to the corres-
ponding polyols by reduction with NaBH 4 ; hexose-1-phosphates are not 
affected and may be determined as above. Reduction was carried out with 
NaBH4, twice the weight of the reducing sugars present, at room tempera-
ture and pH 10 for 2 hours (103). The solution was neutralized with HCl, 
thus destroying excess borohydride, cations were removed with AG50-X4 
(column or batchwise) and borate removed by repeated evaporation with 
methanol (water pump). 
The two methods described above are involved and not practical for 
analysis of multiple samples. It was found much simpler and more conve-
nient to destroy reducing sugars by alkaline hydrolysis followed by 
acid hydrolysis of the hexose-1-phosphates (see "Methods"). The solution 
contains alcohol and tends to bump during alkaline hydrolysis. Loss of 


















Liver none 18 
Liver none 16 
Liver none 15 
Liver none 13 
Kidney none 12 
Brain none 11 
Liver M-15~ 100 
Kidney M-15 79 
Brain M-15 15 
Brain M-60 14 
Liver G-15 14 
Liver G-60 16 

















Results are in nmol/g of tissue, corrected for recoveries, representing 
individual values from 110 to 300 g female rats, except testes as the 
average from 3 males weighing 350 g. 
Man1P was determined after alkaline destruction of reducing sugars, 
except: 
removal of re(lucing sugars by borohydride reduction. 
removal of reducing sugars by enzymic conversion to 6-phosphogluconate. 
M-15, G-15, etc. indicate time in minutes after mannose or glucose 
injection. 
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or a large test tube. A graduated centrifuge tube is used for hydrolysis 
with either H2S04 or HCl. H2S04 is neutralized with Ba(OH)2 and BaS0 4 
is removed from the sample by centrifugation. Excess Ba(OH)2 must be 
avoided because the subsequent assay uses enzyme solutions containing 
ammonium sulfate and the BaS0 4 so formed results in turbidity of the 
assay solution. HCl may be used for the hydrolysis and neutralized with 
KOH; the KCl formed has no adverse effect on the enzymatic reactions 
needed for mannose determination. 
The acid hydrolysate is decolorized with charcoal before neutrali-
zation; decolorization is not as effective if carried out after neutra-
lization. The fact that the hydrolysate became colored, presumably 
because of the presence of amino acids in the tissue extract, raised 
the question as to whether or not this would have any untowards effect 
on the assay. Standard solutions containing the expected level of free 
hexoses and their 6-phosphates along with a mixture of amino acids were 
hydrolyzed according to the above proce~ure; no free sugars were detec-
ted in the alkaline or acid hydrolysate. Mannose-1-phosphate similarly 
treated was quantitatively recovered. Removal of amino acids with cation 
exchanger, AG50-X4 (H+), prior to hydrolysis resulted in lower recoveries 
of ManlP. 
Of concern was whether GDP-Man, if present, would contribute to the 
mannose measured after acid hydrolysis. However, no mannose was detected 
when a known solution of GDP-Man was put through the above procedure. 
Apparently mannose is released on treatment of GDP-Man with alkali and 
thus degraded. Similar treatment of UDP-Glc, which differs from GDP-Man 
only at the hydroxyl group on C2 of the hexose, resulted in the detection 
of glucose in the final acid hydrqlysate. 
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The identity of hexose-1-phosphate present in the alkaline hydro-
lysate was verified by passing the solution through a 4 x 1 em column 
of the anion exchanger AG1-X4 (Ac-). After the hydrolysate (equivalent 
to 5 g liver) was passed through, the column was washed with 10 m1 of 
water followed by 30 ml of 0.01 N HCl and the sugar-phosphates eluted 
with 0.03 N HCl. 3 ml fractions were collected; the sugar-phosphates 
came off in tubes 4, 5 and 6. Hexose-1-phosphates, and any 6-phosphates 
present, would come off together; the fractions were conveniently assayed 
for the presence of Glc1P with PGM and G6PDH. Hexose-6-phosphates were 
not detected in any of the fractions. A sample of the hexose-phosphate 
peak was acid hydrolysed and assayed for glucose, mannose and inorganic 
phosphate (104); the ratio of (glucose+ mannose) : Pi was 0.8 : 1. 
This lack of 1 1 stoichiometry could be due to the presence of other 
phosphorylated compounds that were not separated by the ion-exchange 
procedure. 
Response to Sugar Loading 
Sugar loading, by intraperitoneal injection at a dose of 20 mmol 
per kg of body weight of either glucose, fructose or mannose, was car-
ried out to see what changes it would cause in the concentrations of 
Man6P and Man1P. The method for Man1P determination was developed later 
in the course of the study, thus fewer results are presented for Man1P. 
The levels of hexose-phosphates were determined 15,30 and 60 min after 
the injection of the respective sugars; the results are shown in Tables 
V, VI and VII. The available data indicate a similar pattern of response 
between the younger (60 to 100 g) and older animals ( 150 to 300 g) .• 
Glucose loading. Liver Glc6P was decreased in agreement with the 
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observations of Hers (105); the effect occurred at 30 min after the 
injection. After 60 min the Glc6P level appeared to rebound to a higher 
than normal value. The same pattern was observed with liver Fru6P; the 
levels of Glc6P and Fru6P, 60 min after the injection, appeared to be 
significantly higher than control values (Table V). With these excep-
tions, glucose loading had little effect on hexose-phosphate concen-
trations. 
Fructose loading. An increased level of liver hexose-6-phosphates 
was observed, with the concentrations at 60 min being definitely higher 
than controls (Table VI). In the kidney, peak values (above controls) 
of the 6-phosphates were observed at 30 min. In brain, the levels of 
Glc6P and Man6P, 60 min after the injection, appear to be higher than 
those of controls while Fru6P remains constant throughout the study. 
Mannose loading. Liver Man6P was increased by 4 to 40 times that 
of control (Table VII) and a definite increase of Glc6P and Fru6P was 
also observed 60 min after the injection. Man6P in brain had increased 
15 min after the injection and remained elevated during the 60-minute 
period. In kidney, the level of Man6P appeared elevated at 30 min, but 
normal at 15 and 60 min. Fru6P remained within the normal range in brain 
and kidney. In all tissues elevated values of ManlP were obtained; liver 
and kidney ManlP rose to 7 to 10 times the control levels. Liver ManlP 
also increased after fructose injection (Table VI) but not after glucose 
loading (Table V). 
ATP and Free Hexoses 
Initially we had no interest in determining these metabolites. 

















EFFECT OF GLUCOSE LOADING ON HEXOSE-
PHOSPHATES IN RAT TISSUES 
* Glc6P Fru6P Man6P 
294 72 99 
233 - 50 - 84 -
360 - 80 - 88 -
149 332 47 62 100 80 
92 - 39 - 107 -
77 - 37 - 93 -
575 - 126 - 126 -
42 12 29 
74 - 18 - 43 -
39 43 14 10 48 36 
- 69 - 14 - 26 
92 19 21 














the left of each column are from 150 - 300 g rats, those at the right 
are from 60 - 100 g rats. 
Control values are from Tables I, II and IV. 



















EFFECT OF FRUCTOSE LOADING ON HEXOSE-
PHOSPHATES IN RAT TISSUES 
Glc6P Fru6P Man6P 
294 72 99 
272 - 71 ·- 106 -
327 271 101 73 110 73 
305 230 93 61 129 107 
470 363 110 89 117 78 
842 - 143 - 154 -
42 12 29 
77 - 14 - 28 -
176 159 53 35 115 74 
225 - 52 -. 106 -
65 - 12 - 24 -
92 19 21 
60 71 16 15 24 30 
- 80 - 16 - 32 
- 87 - 19 - 24 











F-15, etc. indicates time, in minutes, after fructose injection. 






















EFFECT OF MANNOSE LOADING ON HEXOSE-
PHOSPHATES IN RAT TISSUES 
Glc6P Fru6P Man6P 
305 202 73 57 410 2620 
247 - 56 - 930 -
398 - 96 - 1910 -
297 - 58 - 440 -
348 - 78 - 1220 -
354 262 89 52 4310 793 
311 274 57 64 1273 942 
540 - 120 - 1560 -
506 - 110 - 1010 -
58 - 10 - 44 -
18 - 3 - 24 -
21 - 9 - 23 -
38 72 13 13 107 82 
57 - 12 - 53 -
54 - 11 - 32 -
130 - 20 - 130 -
56 76 17 16 85 162 
38 - 19 - 128 -
- 95 - 21 - 112 
- 45 - 14 - 195 
95 - 22 -
I 
58 -


















in which the depletion of ATP was suggested as the underlying cause (107) 
prompted us to determine the ATP levels in rat tissues. The determination 
of free hexoses was carried out to see the changes introduced by hexose 
loading and to correlate them with any changes in the phosphorylated 
intermediates. 
The results are presented in Tables VIII and IX. Individual values 
are presented together with the corresponding levels of Glc6P and Man6P 
for the purpose of making correlation with the changes noted in the 
preceding tables. The levels of ATP in the tissues of control animals 
were lower, by about 25 to 30%, than those of reported values (101). 
Control glucose levels are within the reported normal range in both liver 
and brain. 
The concentration of ATP in the blood of the control animal is 
within the reported normal range and remains essentially unaltered by 
the injection of either of the hexoses, glucose, fructose or mannose. 
An increase in blood glucose is observed not only after the injection 
of glucose, but also after mannose and fructose loading. 
The tissue content of ATP decreases after the injection of fructose 
or mannose with a trend of returning to normal after 60 minutes; brain 
ATP is not significantly affected by mannose loading. Liver ATP also 
does not appear to differ from that of control following the injection 
of glucose. In the determination of ATP using hexokinase and G6PDH cau-
tion is necessary since mannose would compete in the hexokinase reaction. 
Therefore, PGI and PMI have to be added to the ATP assay and the proper 
corrections applied. 
The sugars injected into the animals are rapidly excreted by the 







ATP AND FREE HEXOSES IN RAT TISSUES AFTER 
GLUCOSE AND FRUCTOSE LOADING 
Rat II Treatment ATP Glc Fru 
1 control 0.40 4. 77 0 
2 G-15 0.47 19.9 0 
3 G-60 0.46 12.4 0 
4 F-15 0.44 7.70 7.15 
5 F-60 0.55 4.58 1.89 
6 control 1.56 6.74 0 
7 control nd 7.0 0 
8 G-15 1. 91 11.3 0 
9 G-60 1. 58 22.6 0 
3 G-60 1.82 9.5 0 
10 F-15 0.68 7.8 8.8 
11 F-60 1.18 9.03 1.06 
6 control 1.58 1.12 0 
10 F-15 1.05 2.81 1. 17 
11 F-60 1. 75 2.22 0.13 
10 F-15 0.84 5.4 29.2 




















Results are from rats weighing 200-300 g; all values are in ]lmol/g 
(or 1l mol/ml in blood), except Glc6P in nmol/g. 
nd : not determined 
Tissue Rat II 





















ATP AND FREE HEXOSES IN RAT TISSUES 
AFTER MANNOSE LOADING 
Treatment ATP Glc Fru 
M-15 nd 3.0 0 
M-15 0.48 5.79 0 
M-60 0.44 4.2 0 
M-15 0.9 7 8.83 0 
M-15 1. 33 9.3 0 
M-15 nd 8.6 0 
M-15 nd 6.2 0 
M-30 nd 6.7 0 
M-60 nd 15.2 0 
M-60 1. 70 4.7 0 
M-15 2.13 2.46 0 
M-15 nd 1. 33 0 
M-15 nd 2.2 0 
M-30 nd 2.1 0 
M-60 1. 96 1.94 0 
M-15 0.78 3.97 0 
M-15 0.71 4.1 0 
M-60 1. 16 4.23 0 
See Table VIII for explanations. 























in this organ. The tissue concentration of glucose appeared to increase 
slightly after the injection of either fructose or mannose. The increase 
of fructose in the tissues after fructose loading does not reach as high 
a level as that of mannose after mannose loading. Fructose levels in the 
tissues decrease 60 min after fructose loading while tissue glucose re-
mains normal or slightly higher (Table VIII), resulting in an increase 
of the glucose : fructose ratio. On the other hand, the concentration of 
mannose in the tissues after mannose injection remains higher than that 
of glucose, even 60 min after injection; the liver mannose : glucose 
ratio is generally 1.5 to 1.8. Brain mannose appears to be higher at 
30 min after injection and the mannose : glucose ratio changes from about 
1.7 at 15 min to 2.4 (30 min) and 0.93 (60 min). 
GDP-Mannose 
Attempts to detect and determine GDP-Man in rat liver were unsuc-
cessful. The chromatographic method works well with standard solutions: 
GDP-Man was well separated from ATP and ADP on a hydroxyapatite column, 
and from AMP on subsequent elution from a column of AG1-X4. The identity 
of GDP-Man was further verified by TLC on PEl-cellulose and from the 
characteristic absorption spectrum of the guanosine moiety (108). GDP-Man 
was also hydrolyzed by boiling (water bath) for 10 min in 0.01 N HCl, 
resulting in the release of mannose. An eluate of liver extract (HA elu-
ate with 0.01 N K-phosphate buffer pH 6.8) which was subsequently devel-
oped on an AG1-X4 column showed several ultraviolet absorbing peaks, but 
GDP-Man was not detected in any of the fractions. 
The isolation of GDP-Man dehydrogenase from A. viscosus was also 
unsuccessful. It was learned later that the bacteria had undergone 
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mutation (Dr. Jack Preiss, communication with Dr. Koeppe). 
Recently, Sudarat Manochiopinig in our laboratory has found this 




The preparation of tissues for the study of metabolite levels 
requires rapid "freezing" of metabolic processes, either by the use of 
refrigerants such as liquid nitrogen or Freon cooled with liquid nitro-
gen or by microwave heating. Several variants of this basic principle, 
directed towards the arrest of anoxic/ischemic changes, have been 
reported in the literature. The animals used may be anesthetized or not; 
however, no single procedure applicable for obtaining different tissues 
from an individual animal has been described. The simplest procedure, 
of freezing the whole animal in a refrigerant, is not satisfactory except 
for very small, young animals. 
The best method of obtaining brain samples is by freeze-blowing 
(98), although this method does not allmv regional studies to be done. 
Microwave irradiation has been shown to give results different from 
those obtained by freeze-blowing. The differences were not attributable 
simply to anoxia. Rather, the changes seem to reflect the different 
thermal characteristics of the various enzymes which must be denatured 
to stop metabolism of the substrate to be measured ( 109). A study of 
the changes in phosphocreatine, ATP and lactate showed that fixation of 
brain by innnersion in liquid nitrogen approximates that by freeze-blow-
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ing more closely than does microwave irradiation (110). 
Swaab (111) demonstrated that the skin of the skull was the most 
important insulator; cortical temperature would drop to 0°C in 3.8 sec 
if the skin was removed compared to 30 sec if the skin was left intact. 
The initial cooling with liquid nitrogen was as fast as with Freon at 
its melting point, but eventually cooling with liquid nitrogen was 
faster. Mouse brain 6 mm below the skull reached -4o 0c within 20 sec 
(intact head, 112). 
Other organs can be quickly frozen by freeze-clamping between two 
metal plates chilled to liquid nitrogen temperature. Since this method 
is not always practical or convenient for all organs, satisfactory re-
sults may be obtained by quickly removing a small piece of tissue from 
an anesthetized animal and immersing it in liquid nitrogen. Alternatively 
the tissue can be exposed, under ether anesthesia, and flooded with the 
refrigerant (100). 
The methods mentioned necessitate the use of anesthetics, thus 
introducing another variable while solving the problem of easy access 
to the desired tissues. Anesthetics in general cause a depression of 
metabolic rates. There was no significant alteration in the level of 
adenine nucleotides of brain under anesthesia with phenobarbital while 
glucose and Glc6P were higher than the control values (99). Dale (113) 
cosidered nembutal unsatisfactory because of the long induction period 
and ether anesthesia preferable to represent the concentration of meta-
bolites in vivo. However, ether will elicit a sympathetic response, 
causing the release of catecholamines, with the concomitant increase in 
glycogenolysis and lipolysis (114). 
With so many variables involved it is not surprising to see a wide 
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range of control values reported in the literature (100); representative 
values are presented in Table X. Faupel et al. (115) introduced the 
double-hatchet method for sampling rat liver whereby the animal was cut 
in one stroke at the neck and just below the chest. The method obviates 
the use of anesthetics; liver samples could be obtained and frozen bet-
ween cooled aluminum blocks within 3.5 sec. 
In the present study rats anesthetized with ether were used so that 
different tissue samples could be obtained from one animal. The levels 
of Glc6P and Fru6P in liver and kidney are within the reported range of 
normal values, while those of brain are lower than those obtained by 
freeze-blowing but in agreement with the values obtained by freezing 
in-situ with the skull exposed. The lower concentration of ATP obtained 
in the limited number of control samples suggests that anoxic changes 
may have occurred, at least in some samples. 
There is room for improvement in the sampling procedure and a modi-
fication of the double-hatchet method seems most promising for obtaining 
multiple samples from a single animal. This would be preferable to the 
usual procedure of obtaining different tissues from a number of animals 
because a better appraisal of the effect of a stimulus (e.g. mannose 
loading) on the whole animal could be obtained. A multiple hatchet that 
would cover the whole length of the animal, with the blades separated 
by about 5 mm or less, would serve the purpose. The animal is placed in 
a chamber (disposable, if desired) in which it has been acclimatized 
to minimize or avoid any stressful effect and the hatchet is struck down 
on the unanesthetized animal which is then immediately covered with 
liquid nitrogen. The freezing process would be faster using a precooled 










CONCENTl{J\'J'ION Of METABOLITES REPORTED 
IN THE LITERATURE 
Glc6P Fru6P ATP 
95 nd 3.0 
116 nd 2.45 
159 51 2.36 
153 33 nd 
160 50 2.74 
278 76 3.4 
229-253 33-40 1. 89-2.01 
195-370 nd nd 
39 13 1.43 
Freezing in-situ, halothane anesthesia for 60 min. 
Whole body immersion, unanesthetized. 
Freeze-blown, pentobarbital anesthesia for 20 min. 













3 Cervical dislocation, open abdomen, tissue excised and freeze-clamped. 
§ § 
Freeze-clamp in-situ, ether anesthesia 
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sharp under the freezing and warming stress. 
It is desirable for statistical purposes to obtain and prepare the 
extract of the different tissues from the control and the variously 
treated animals on the same day. Because it is not possible to assay 
these extracts immediately, it is necessary to determine the stability 
of the metabolites in stored extracts. 
Mannose-phosphates and Related Metabolites 
This study describes the presence of Man6P and Man1P in rat tissues: 
brain, liver, kidney and testes. The concentration of Man6P in brain of 
about 20 to 50 nmol/g is much lower than that reported earlier (about 
320 nmol/g) by Sloviter et al. (1). Except for testes, the levels of 
Man6P are higher than those of Fru6P with the ratio of Man6P : Fru6P in 
the range of 1.4 to 3, which is not far removed from the equilibrium 
value of about 1.0 reported for the reaction catalyzed by yeast PMI (76). 
The concentration of Man6P in liver appears to be slightly increased 
after glucose injection. The rise in liver Man6P is definite 60 minutes 
after fructose loading, with the ratio Man6P : Fru6P remaining essen-
tially constant (Tables I- VI). 
The concentration of Man6P, following mannose loading, is increased 
in the liver, brain and kidney. Liver Man6P varies between 4 and 40 times 
that found in controls and is accompanied by a similar increase of Man1P. 
Brain Man6P is about 3 to 10 times control values during the 60-minute 
period after mannose loading, while kidney Man6P appears to reach a 
peak of 2 to 3 times that of control 30 min after the injection. Although 
the data are limited, an .increase of Man1P is also apparent in kidney 
and brain. These observations suggest the interconversion of Man6P and 
ManlP in rat tissues. It is still unknown what enzyme, if any, is in-
volved in the interconversion because PMM has so far not been detected 
in rat tissuesl. 
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The phosphorylation of mannose to Man6P could be carried out by the 
enzymes hexokinase or glucokinase. Glucokinase activity is known to be 
decreased by diabetes or fasting (120) and it would be of interest to 
follow the effect of mannose loading in these conditions. 
A fall in ATP is observed after fructose or mannose loading; the 
decrease of liver ATP correlates quite well with the increase of Man6P. 
This fall of ATP after mannose injection is similar to that after fruc-
tose, sorbitol or glycerol loading (121), in which the formation of 
phosphorylated products is followed by a rate limiting step. Brain ATP 
appears to be within the normal level, presumably because of the rela-
tively low increase of Man6P. 
GDP-Mannose 
A look at the literature (54 - 61) reveals that a sizable quantity 
of materials were used for the isolation of GDP-mannose. Anion exchang~ 
chromatography was invariably used, and the separation of nucleotides 
required a large volume of eluant, a formate gradient in most cases. The 
values reported did not mention the possibility'of losses occurring, 
among others, because of overlapping peaks; GDP-Man follows ADP in the 
formate system and elutes after ATP when a calcium chloride gradient is 
used (95). 
In this study we wanted to quantitate the levels of GDP-mannose in 
1J. Ledford and S. Manochiopinig, personal communication. 
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tissues, starting with a small amount of material. Clearly, the methods 
above are not directly applicable for this purpose. The fact that hyd-
roxyapatite retains nucleotide di- and tri-phosphates and not sugar 
nucleotides (94) appears useful for the pretreatment of tissue extracts 
before fractionation on an ion exchange column. This was verified by 
using known solutions of nucleotide mixtures. However, we failed to 
detect any GDP-mannose in liver extracts. This failure might be attrib-
utable to a low level of GDP-Man in liver and possible degradation dur-
ing the acid extraction process. It would be useful to try the above 
strategy on a convenient source such as egg-white, in which most of the 
nucleotide present is GDP-Man (56), or pig's milk (61)! Various proce-
dures have been reported which might be useful as alternatives, or in 
addition to, the above strategy. 
It is unfortunate that the enzymatic method, which seems to be more 
specific and convenient, could not be used for the time being, because 
of the mutation of the bacteria used as the enzyme source. Work is still 
being carried out in this lab to isolate the enzyme using a new batch of 
bacteria from Dr. Preiss (S. Manochiopinig); 
CHAPTER V 
SUMMARY 
The determination of mannose-phosphates in rat tissues has been 
accomplished using an enzymatic assay coupled to the formation of NADPH, 
the fluorescence of which is measured. Mannose-6-phosphate is present 
in brain, liver, kidney and testes at concentrations of 21, 100, 29 and 
12 nmol/g, respectively. 
Mannose-1-phosphate is present in these tissues at concentrations 
ranging from 3 nmol/g in the testes to about 15 nmol/g in liver. The 
method for the determination of mannose-1-phosphate has been described 
in detail. Several procedures were tried for this determination, the 
most convenient being the enzymatic measurement of free mannose produced 
from mannose-1-phosphate by sequential alkaline and acid hydrolysis of 
tissue extracts. 
Following intraperitoneal injection of mannose (20 mmol/kg body 
weight) the concentration of mannose-6-phosphate and mannose-1-phosphate 
is increased in liver and brain. Although phosphomannomutase activity 
has not been detected in mammalian tissue, these results suggest that 
mannose-6-phosphate may be the precursor of mannose-1-phosphate. 
Attempts to measure GDP-mannose by chromatographic and enzymatic 
means failed; the rationale behind the approach and the probable causes 
of failure are discussed. 
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APPENDIX 
DETERMINATION OF RECOVERY AND CONCENTRATION 
OF METABOLITES 
A tissue sample is divided into two portions, m gram is used for 
the determination of the metabolite X and n gram for the assay with a 
known amount, s, of a standard solution of X added. It is desired to 
determine the concentration of the metabolite per g of tissue, x, and 
the percentage recovery, p. 
Let the amount of X found in m gram of tissue = M, and the amount 
in n gram (with s added) = N. The original concentration of X in the 




p(xn + s)/100 
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